Anthem (NASDAQ:ANTX) Downgraded to “Sell” Rating by Wall Street Zen

Anthem (NASDAQ:ANTX) was downgraded by equities research analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Saturday.

Separately, Weiss Ratings assumed coverage on Anthem in a report on Tuesday, April 7th. They set a “sell (d-)” rating for the company. One research analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $2.00.

Anthem Stock Performance

Shares of NASDAQ ANTX opened at $4.34 on Friday. Anthem has a 52 week low of $1.00 and a 52 week high of $6.91. The stock has a market capitalization of $156.24 million, a P/E ratio of -3.74 and a beta of -1.31. The stock’s fifty day moving average is $3.09 and its 200 day moving average is $1.83.

Anthem (NASDAQ:ANTX) last issued its quarterly earnings results on Tuesday, March 17th. The company reported ($0.29) EPS for the quarter. Equities research analysts forecast that Anthem will post -0.91 earnings per share for the current year.

Anthem Company Profile

Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional indemnity plans and other hybrid plans, such as consumer-driven health plans; and hospital only and limited benefit products.